Dr. Flaherty is director of the Henri and Belinda Termeer Center for Targeted Therapies at the Mass General Cancer Center and Associate Professor of Medicine at Harvard Medical School. Dr. Flaherty's research and clinical focus is therapies for melanoma, with a particular expertise in targeted therapies. He has been the principal investigator of many clinical trials, including first-in-human trials of novel targeted therapies, and two NCI cooperative group trials. He is a member of numerous scientific cancer societies and national committees, and has authored many research articles, abstracts and reviews in the peer-reviewed literature; including 3 first-author New England Journal of Medicine papers.